Ireland· IE-PA-EU/1/19/1381/001
LysaKare 25 g/25 g Solution for infusion
A arginin und lysin product containing l-lysine hydrochloride + l-arginine hydrochloride, registered in Ireland by Novartis Europharm Limited. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Arginin und lysin is registered in 8 of 19 countries.
Countries holding a registration under ATC V03AF11 (arginin und lysin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Arginin und lysin · ATC V03AF11
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- L-lysine hydrochloride + L-arginine hydrochloride
- Manufacturer
- Novartis Europharm Limited
- Country
- Ireland (IE)
- ATC code
- V03AF11
- ATC class
- Arginin und Lysin
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/19/1381/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Arginin und lysin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomArginine 25g/1litre / Lysine 25g/1litre infusion bagsSpecial Order
- SpainLYSAKARE 25 G/25 G SOLUCION PARA PERFUSIONNovartis Europharm Limited
- FinlandLysakareNovartis Europharm Limited
- FranceLYSAKARE 25 g/25 g, solution pour perfusionNOVARTIS EUROPHARM (IRLANDE)
- IcelandLysaKareNovartis Europharm Limited*
- PolandLysaKareAdvanced Accelerator Applications
- CzechiaLYSAKARENovartis Europharm Limited, Dublin
- SwedenLysaKare 25 mg / 25 mg Infusionsvätska, lösningNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lysakare
- Liechtenstein · Lysakare
- Norway · Lysakare
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2ff9a94-75c0-4391-95d4-3d8e321536b0 GET /v1/drugs/f2ff9a94-75c0-4391-95d4-3d8e321536b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"V03AF11"
],
"strength": null,
"pa_number": "EU/1/19/1381/001",
"substances": [
"L-lysine hydrochloride",
"L-arginine hydrochloride"
],
"legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "25/07/2019",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about arginin und lysin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.